Related Experiment Videos
Human cartilage proteoglycans isolated from normally ossifying and congenitally malformed leg bones
Insights
Altered proteoglycans in congenital limb defects suggest metabolic pathway involvement. Cartilage proteoglycan analysis reveals key differences in limb malformations.
Area of Science:
- Biochemistry
- Developmental Biology
- Orthopedics
Background:
- Proteoglycans are crucial extracellular matrix components in cartilage, influencing tissue structure and function.
- Congenital limb defects represent a significant challenge in pediatric orthopedics, with complex underlying etiologies.
- Understanding proteoglycan metabolism is vital for elucidating normal skeletal development and pathological conditions.
Observation:
- Proteoglycans were extracted from human epiphyseal cartilages of a fibula and a rudimentary tibia in a patient with congenital absence of the tibia.
- Proteoglycan preparations were fractionated into heavy and light components using sucrose density gradient centrifugation.
- Differences in molecular size and isomeric chondroitin sulfate proportions were noted between the heavy and light proteoglycan components.
Findings:
- The molecular size and isomeric chondroitin sulfate composition of proteoglycan components varied between different cartilage zones.
- While glycosaminoglycan content was similar between the rudimentary tibia and fibula cartilage, proteoglycan preparations from the rudimentary tibia lacked normal sedimentation profiles and zonal differences.
- These findings indicate aberrant proteoglycan organization and composition in the context of a congenital limb defect.
Implications:
- Alterations in proteoglycan metabolism may play a role in the pathogenesis of congenital limb defects.
- This study highlights the potential of proteoglycan analysis as a diagnostic or research tool for limb malformations.
- Further investigation into specific proteoglycan modifications could reveal novel therapeutic targets for congenital skeletal disorders.
Abstract:
Proteoglycans were extracted with 4 M guanidine HCl solution containing protease inhibitors from various zones of human epiphyseal cartilages of the normally ossifying fibula and cartilaginous rudiment of the tibia of a 12-month-old boy with congenital absence of the tibia, when the knee disarticulation was performed. All the proteoglycan preparations from the epiphyseal cartilages were separated with a sucrose density gradient centrifugation into two components: a heavy, major component and a light one. The molecular size and the proportion of isomeric chondroitin sulfates of polysaccharides of the heavy component differed from those of the light one. The relative amounts of isomeric chondroitin sulfates in the polysacharide moieties of the components also varied among these zones. The glycosaminoglycan content in the rudimentary tibia was equal to that of the epiphyseal cartilage of the fibula. However, proteoglycan preparations showed neither the normal sedimentation profile with two peaks nor the zonal differences as to the proportion of isomeric chondroitin sulfates. These results suggest that the alterations in proteoglycan metabolism might be involved in the pathogenetic mechanisms producing the congenital limb defect.